Alzheimer's Disease Research in Under-Represented Groups

Carey Gleason, PhD, is a researcher and clinician interested in improving timely identification of and intervention for memory disorders in underserved communities. 

Her research strives to improve the diagnosis and treatment of Alzheimer’s disease (AD) and dementia for all individuals, including women, African Americans, Native Americans, and other groups traditionally under-represented in research. The lab is founded on the premise that diversity makes for better science. The belief that research discoveries should benefit all groups unifies seemingly disparate lines of scientific inquiry. 

Dr. Carey Gleason


View a list of Dr. Gleason's publications.